Recce Pharmaceuticals Expands Market Presence
Company Announcements

Recce Pharmaceuticals Expands Market Presence

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.

Recce Pharmaceuticals Ltd. has announced a new application for the quotation of securities, specifically 9,844,296 ordinary shares, on the ASX under the code RCE, with an issue date of August 6, 2024. This move indicates a potential expansion of Recce Pharmaceuticals’ financial footprint and an opportunity for investors to engage with the company’s growth.

For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Boosted by $6.75M R&D Rebate
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Issues New Options for Growth
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Advances Phase 3 Trial in Indonesia
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App